Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study

OBJECTIVES: To analyse the impact of cefiderocol use on outcome in patients admitted to the ICU for severe COVID-19 and further diagnosed with carbapenem-resistant Acinetobacter baumannii (CR-Ab) infection. METHODS: Retrospective multicentre observational study was performed at four Italian hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Pascale, Renato, Pasquini, Zeno, Bartoletti, Michele, Caiazzo, Luca, Fornaro, Giacomo, Bussini, Linda, Volpato, Francesca, Marchionni, Elisa, Rinaldi, Matteo, Trapani, Filippo, Temperoni, Chiara, Gaibani, Paolo, Ambretti, Simone, Barchiesi, Francesco, Viale, Pierluigi, Giannella, Maddalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599913/
https://www.ncbi.nlm.nih.gov/pubmed/34806011
http://dx.doi.org/10.1093/jacamr/dlab174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599913/
https://www.ncbi.nlm.nih.gov/pubmed/34806011
http://dx.doi.org/10.1093/jacamr/dlab174

Ejemplares similares